FindTrial
Sign In

A study on male equivalent of polycystic ovary syndromes in male patients of acne grade 3 and 4.

A cross sectional study on clinical, hormonal and metabolic parameters of male equivalent of polycystic ovary syndrome in male patients presenting with grade 3 and grade 4 acne vulgaris.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/10/046452
Enrollment
80
Registered
2022-10-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

None listed

Sponsors

ICMR Indian council of medical research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age more than equal to 18 years. 2. Male patient with acne grade 3 and 4. 3. Patient willing to sign informed consent form

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years. 2. Female patients of all age. 3. Male patients with acne grade 1 and 2. 4. Patient not willing to sign informed consent form. 5. Patients with underlying any endocrinological abnormality except type 2 diabetes mellitus which might interfere with study findings. 6. Patients taking oral corticosteroids taking for any medical conditions which might interfere with study findings. 7. Patients taking any hormonal therapy which might interfere with study results. 8. Patients taking any protein powders and sports medicines for body building which might interfere with study findings. 9. patients with underlying haematological and psychiatric disease. 10. Patients with underlying malignancy and paraneoplastic syndrome which might interfere with study results. 11. Major medical and surgical illness in past 4 months which might interfere with laboratory parameters in the study. 12. Patient taking herbal, homeopathic or any other alternative medicines which might interfere with study results. 13. Patients with any addictions.

Design outcomes

Primary

MeasureTime frame
1.To estimate the hospital-based prevalence of ME-PCOS in male patients with acne grade 3 & 4. 2. To estimate the hospital-based prevalence of other cutaneous markers of ME-PCOS in male patients with acne grade 3 & 4. 3. To estimate hospital-based hormonal and metabolic derangements in male patients with acne grade 3 & 4. Timepoint: at baseline visit: single point cross sectional study—

Secondary

MeasureTime frame
1. To determine any corelation if any, between various clinical parameters of ME-PCOS and laboratory parameters (hormonal and metabolic). 2. To determine any correlation between various clinical and laboratory parameters with the diet taken by the patients on regular bases. Timepoint: at baseline visit - single point cross sectional study—

Countries

India

Contacts

Public ContactJignaben Krunal Padhiyar

GCSMCH&RC

dr.jignapadhiyar@gmail.com09909966702

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026